skip to content

Department of Veterinary Medicine

Cambridge Veterinary School
 

Utility of a Modified Penlight-Cover Test for Neurolocalization of Lesions Based on Visual Suppression of Nystagmus in Dogs and Cats With Vestibular Disease

Latest publications - Fri, 27/06/2025 - 11:00

J Vet Intern Med. 2025 Jul-Aug;39(4):e70182. doi: 10.1111/jvim.70182.

ABSTRACT

BACKGROUND: Humans with peripheral vestibular disorders can suppress nystagmus through visual fixation, a capability often compromised in those with central vestibular disorders. Bedside tests that exploit this difference can aid neurolocalization in humans. These tests remain unexplored in veterinary medicine.

HYPOTHESIS: Removal of visual input will reveal or enhance nystagmus in animals with peripheral vestibular disease, while animals with central vestibular disease would show little change.

ANIMALS: Twenty-one dogs and cats with peripheral vestibular lesions and 16 with central vestibular lesions. Diagnosis was confirmed by MRI.

METHODS: A prospective study was conducted using a modified penlight-cover test. Because animals cannot be easily instructed to fixate on a visual target, removal of visual input was used as a substitute for eliminating visual fixation, based on the assumption that visual fixation also occurs spontaneously. A 0.5-W LED penlight was shined into one eye while covering the other to eliminate visual input. Nystagmus beat frequency (BF) and subjective evaluation of slow phase velocity (SPV) were recorded before and during penlight application.

RESULTS: In animals with peripheral lesions, BF increased in 33% and SPV in 24% of cases after removal of visual input. Among those with central lesions, only one of 16 showed an increase in BF, and none exhibited an increase in SPV.

CONCLUSIONS: When used alongside the neurological examination, the modified penlight-cover test, could raise suspicion of a peripheral vestibular lesion if it reveals increased BF or SPV.

PMID:40577055 | DOI:10.1111/jvim.70182

Tubular retractors in neuro-oncological surgery: a systematic review and meta-analysis

Latest publications - Fri, 27/06/2025 - 11:00

Neurosurg Rev. 2025 Jun 27;48(1):530. doi: 10.1007/s10143-025-03677-w.

ABSTRACT

Neuro-oncological surgery necessitates a careful balance between maximising tumour resection whilst minimising damage to healthy brain parenchyma. Tubular retractors represent an emerging tool proposed to facilitate in the optimisation of this onco-functional balance. The objective was to evaluate the evidence regarding tubular retractors in neuro-oncological surgery. A systematic review and meta-analysis was performed. Studies reporting on surgical outcomes of tubular retractors in adult neuro-oncological cases were eligible. Medline, Embase, Cochrane Library, ClinicalTrials.gov, and ICTRP were searched to 14th July 2024. Duplicate title/abstract screening, data extraction, and risk of bias assessments were conducted. Prevalence of gross total resection (GTR) and complications were calculated using random effects models. 49 studies were included in the final analysis with a total of 684 patients. Combined pooled prevalence for GTR was 76% (95% CI: 67-85%), whilst for complications was 14% (95% CI: 8-20%). GTR rate by tumour histology was: 52% for gliomas (95% CI: 41-62%), 80% for metastases (95% CI: 65-92%), and 100% for colloid cysts (95% CI: 99-100%). Complication rate by tumour histology was: 16% for gliomas (95% CI: 5-30%), 12% for metastases (95% CI: 1-28%), and 16% for colloid cysts (95% CI: 8-24%). There was no significant difference between tubular retractor brands and GTR or complication rate (p > 0.05). Despite the mounting interest regarding the utility of tubular retractors in neuro-oncological surgery, the current evidence remains largely in the form of case series. Prospective studies with greater sample sizes, longer follow-up, and direct comparison to conventional retraction are now needed.

PMID:40576849 | DOI:10.1007/s10143-025-03677-w

Guidelines for preventing and reporting contamination in low-biomass microbiome studies

Latest publications - Fri, 20/06/2025 - 11:00

Nat Microbiol. 2025 Jun 20. doi: 10.1038/s41564-025-02035-2. Online ahead of print.

ABSTRACT

Numerous important environments harbour low levels of microbial biomass, including certain human tissues, the atmosphere, plant seeds, treated drinking water, hyper-arid soils and the deep subsurface, with some environments lacking resident microbes altogether. These low microbial biomass environments pose unique challenges for standard DNA-based sequencing approaches, as the inevitability of contamination from external sources becomes a critical concern when working near the limits of detection. Likewise, lower-biomass samples can be disproportionately impacted by cross-contamination and practices suitable for handling higher-biomass samples may produce misleading results when applied to lower microbial biomass samples. This Consensus Statement outlines strategies to reduce contamination and cross-contamination, focusing on marker gene and metagenomic analyses. We also provide minimal standards for reporting contamination information and removal workflows. Considerations must be made at every study stage, from sample collection and handling through data analysis and reporting to reduce and identify contaminants. We urge researchers to adopt these recommendations when designing, implementing and reporting microbiome studies, especially those conducted in low-biomass systems.

PMID:40542287 | DOI:10.1038/s41564-025-02035-2

Cambridge researchers awarded Advanced Grants from the European Research Council

Departmental research news - Tue, 17/06/2025 - 11:00

The successful Cambridge grantees’ work covers a range of research areas, including the development of next-generation semiconductors, new methods to identify dyslexia in young children, how diseases spread between humans and animals, and the early changes that happen in cells before breast cancer develops, with the goal of finding ways to stop the disease before it starts.

The funding, worth €721 million in total, will go to 281 leading researchers across Europe. The Advanced Grant competition is one of the most prestigious and competitive funding schemes in the EU and associated countries, including the UK. It gives senior researchers the opportunity to pursue ambitious, curiosity-driven projects that could lead to major scientific breakthroughs. Advanced Grants may be awarded up to € 2.5 million for a period of five years. The grants are part of the EU’s Horizon Europe programme. The UK agreed a deal to associate to Horizon Europe in September 2023.

This competition attracted 2,534 proposals, which were reviewed by panels of internationally renowned researchers. Over 11% of proposals were selected for funding. Estimates show that the grants will create approximately 2,700 jobs in the teams of new grantees. The new grantees will be based at universities and research centres in 23 EU Member States and associated countries, notably in the UK (56 grants), Germany (35), Italy (25), the Netherlands (24), and France (23).

“Many congratulations to our Cambridge colleagues on these prestigious ERC funding awards,” said Professor Sir John Aston, Cambridge’s Pro-Vice-Chancellor for Research. “This type of long-term funding is invaluable, allowing senior researchers the time and space to develop potential solutions for some of biggest challenges we face. We are so fortunate at Cambridge to have so many world-leading researchers across a range of disciplines, and I look forward to seeing the outcomes of their work.”

The Cambridge recipients of 2025 Advanced Grants are:

Professor Clare Bryant (Department of Veterinary Medicine) for investigating human and avian pattern recognition receptor activation of cell death pathways, and the impact on the host inflammatory response to zoonotic infections.

Professor Sir Richard Friend (Cavendish Laboratory/St John’s College) for bright high-spin molecular semiconductors.

Professor Usha Goswami (Department of Psychology/St John’s College) for a cross-language approach to the early identification of dyslexia and developmental language disorder using speech production measures with children.

Professor Regina Grafe (Faculty of History) for colonial credit and financial diversity in the Global South: Spanish America 1600-1820.

Professor Judy Hirst (MRC Mitochondrial Biology Unit/Corpus Christi College) for the energy-converting mechanism of a modular biomachine: Uniting structure and function to establish the engineering principles of respiratory complex I.

Professor Matthew Juniper (Department of Engineering/Trinity College) for adjoint-accelerated inference and optimisation methods.

Professor Walid Khaled (Department of Pharmacology/Magdalene College) for understanding precancerous changes in breast cancer for the development of therapeutic interceptions.

Professor Adrian Liston (Department of Pathology/St Catharine’s College) for dissecting the code for regulatory T cell entry into the tissues and differentiation into tissue-resident cells.

Professor Róisín Owens (Department of Chemical Engineering and Biotechnology/Newnham College) for conformal organic devices for electronic brain-gut readout and characterisation.

Professor Emma Rawlins (Department of Physiology, Development and Neuroscience/Gurdon Institute) for reprogramming lung epithelial cell lineages for regeneration.

Dr Marta Zlatic (Department of Zoology/Trinity College) for discovering the circuit and molecular basis of inter-strain and inter-species differences in learning

“These ERC grants are our commitment to making Europe the world’s hub for excellent research,” said Ekaterina Zaharieva, European Commissioner for Startups, Research, and Innovation. “By supporting projects that have the potential to redefine whole fields, we are not just investing in science but in the future prosperity and resilience of our continent. In the next competition rounds, scientists moving to Europe will receive even greater support in setting up their labs and research teams here. This is part of our “Choose Europe for Science” initiative, designed to attract and retain the world’s top scientists.”

“Much of this pioneering research will contribute to solving some of the most pressing challenges we face - social, economic and environmental,” said Professor Maria Leptin, President of the European Research Council. “Yet again, many scientists - around 260 - with ground-breaking ideas were rated as excellent, but remained unfunded due to a lack of funds at the ERC. We hope that more funding will be available in the future to support even more creative researchers in pursuing their scientific curiosity.”

Eleven senior researchers at the University of Cambridge have been awarded Advanced Grants from the European Research Council – the highest number of grants awarded to any institution in this latest funding round.

Westend61 via Getty ImagesScientist pipetting samples into eppendorf tube


The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

Yes

Multiple introductions of equine influenza virus into the United Kingdom resulted in widespread outbreaks and lineage replacement

Latest publications - Mon, 09/06/2025 - 11:00

PLoS Pathog. 2025 Jun 9;21(6):e1013227. doi: 10.1371/journal.ppat.1013227. Online ahead of print.

ABSTRACT

Influenza A viruses (IAVs) are prime examples of emerging viruses in humans and animals. IAV circulation in domestic animals poses a pandemic risk as it provides new opportunities for zoonotic infections. The recent emergence of H5N1 IAV in cows and subsequent spread over multiple states within the USA, together with reports of spillover infections in humans, cats and mice highlight this issue. The horse is a domestic animal in which an avian-origin IAV lineage has been circulating for >60 years. In 2018/19, a Florida Clade 1 (FC1) virus triggered one of the largest epizootics recorded in the UK, which led to the replacement of the Equine Influenza Virus (EIV) Florida Clade 2 (FC2) lineage that had been circulating in the country since 2003. We integrated geographical, epidemiological, and virus genetic data to determine the virological and ecological factors leading to this epizootic. By combining newly-sequenced EIV complete genomes derived from UK outbreaks with existing genomic and epidemiological information, we reconstructed the nationwide viral spread and analysed the global evolution of EIV. We show that there was a single EIV FC1 introduction from the USA into Europe, and multiple independent virus introductions from Europe to the UK. At the UK level, three English regions (East, West Midlands, and North-West) were the main sources of virus during the epizootic, and the number of affected premises together with the number of horses in the local area were found as key predictors of viral spread within the country. At the global level, phylogeographic analysis evidenced a source-sink model for intercontinental EIV migration, with a source population evolving in the USA and directly or indirectly seeding viral lineages into sink populations in other continents. Our results provide insight on the underlying factors that influence IAV spread in domestic animals.

PMID:40489557 | DOI:10.1371/journal.ppat.1013227

Characterisation of <em>Ornithobacterium hominis</em> colonisation dynamics and interaction with the nasopharyngeal microbiome in a South African birth cohort

Latest publications - Fri, 06/06/2025 - 11:00

bioRxiv [Preprint]. 2025 May 24:2025.05.24.655922. doi: 10.1101/2025.05.24.655922.

ABSTRACT

Ornithobacterium hominis is a recently described Gram-negative bacterium that colonises the human nasopharynx and may be associated with poor upper respiratory tract health. Here, we describe the isolation of O. hominis from samples collected from a South African birth cohort, creating the first archive of cultured strains of the species from Africa. Sequenced genomes from this archive reveal that South African O. hominis is more similar to Australian strains than those from Southeast Asia, and that it may share genes with other members of the microbiome that are relevant for virulence, colonisation, and antibiotic resistance. Leveraging existing microbiome data from the cohort, O. hominis was found to be closely associated with bacterial co-colonisers that are rare in non-carrier individuals, including Suttonella, Helcococcus, Moraxella spp., and Gracilibacteria. Their collective acquisition has a significant impact on the diversity of nasopharyngeal communities that contain O. hominis. Individuals who have not yet acquired O. hominis have a higher abundance of Moraxella (particularly M. lincolnii) than individuals who never acquire O. hominis, suggesting that this could be a precursor state for successful colonisation. Finally, a novel co-coloniser species, Helcococcus ekapensis, was successfully isolated and sequenced.

PMID:40475515 | PMC:PMC12139837 | DOI:10.1101/2025.05.24.655922

How does policy modelling work in practice? A global analysis on the use of epidemiological modelling in health crises

Latest publications - Fri, 06/06/2025 - 11:00

PLOS Glob Public Health. 2025 Jun 6;5(6):e0004675. doi: 10.1371/journal.pgph.0004675. eCollection 2025.

ABSTRACT

This study examines the use and translation of epidemiological modelling by policy and decision makers in response to the COVID-19 outbreak. Prior to COVID-19, there was little readiness for global health systems, and many science-policy networks were assembled ad-hoc. Moreover, in the field of epidemiological modelling, one with significant sudden influence, there is still no international guidance or standard of practice on how modelled evidence should guide policy during major health crises. Here we use a multi-country case study on the use of epidemiological modelling in emergency COVID-19 response, to examine the effective integration of crisis science and policy in different countries. We investigated COVID-19 modelling-policy systems and practices in 13 countries, spanning all six UN geographic regions. Data collection took the form of expert interviews with a range of national policy/ decision makers, scientific advisors, and modellers. We examined the current use of epidemiological modelling, introduced a classification framework for outbreak modelling and policy on which best practice can be structured, and provided preliminary recommendations for future practice. Full analysis and interpretation of the breadth of interview responses is presented, providing evidence for the current and future use of modelling in disease outbreaks. We found that interviewees in countries with a similar size and type of modelling infrastructure, and similar level of government interaction with modelling reported similar experiences and recommendations on using modelling in outbreak response. From this, we introduced a helpful grouping of country experience upon which a tailored future best practice could be structured. We concluded the article by outlining context-specific activities that modellers and policy actors could consider implementing in their own countries. This article serves as a first evidence base for the current use of modelling in a recent major health crisis and provides a robust framework for developing epidemiological modelling-to-policy best practice.

PMID:40478854 | DOI:10.1371/journal.pgph.0004675

The Value of Neutrophil Cell Population Data Parameters as Markers of Systemic Inflammation in Dogs and Cats

Latest publications - Fri, 06/06/2025 - 11:00

Vet Clin Pathol. 2025 Jun 6. doi: 10.1111/vcp.70029. Online ahead of print.

ABSTRACT

BACKGROUND: Neutrophil cell population data (CPD), including fluorescent light intensity (NE-SFL) and side scatter (NE-SSC), are promising inflammatory markers in human sepsis but remain unexplored in dogs and cats.

OBJECTIVES: Determine the diagnostic utility of NE-SSC and NE-SFL for detecting systemic inflammation in dogs and cats.

METHODS: Dogs and cats with archived CPD, blood films, and acute phase protein (APP) measurements were included. Increased C-reactive protein (CRP) in dogs and Serum Amyloid A (SAA) in cats were considered indicative of systemic inflammation. CPD was compared with APPs, white cell count (WCC), neutrophil count, band neutrophil count, and toxic change grade. Optimal cut-offs and associated sensitivities and specificities were calculated using ROC curve analysis. Correlations were assessed using Spearman's coefficient.

RESULTS: NE-SFL and NE-SSC were significantly increased in dogs and cats with systemic inflammation. The area under the curve (AUC) of NE-SFL was higher than that of NE-SSC, WCC, and band neutrophil count in both dogs (0.82) and cats (0.77). The optimal NE-SFL cut-off for detecting systemic inflammation was > 41.7 ch in dogs (sensitivity 80%; specificity 66%) and > 37.4 ch in cats (sensitivity 75%; specificity 67%). NE-SFL was positively correlated with APPs, WCC, neutrophil count, and band neutrophil count in both species. NE-SSC was positively correlated with APPs in both species and, in dogs, also with WCC, neutrophil count, and band neutrophil count.

CONCLUSION: CPD, particularly NE-SFL, is a promising marker of inflammation in dogs and cats and could be especially useful when APP quantification or blood smear examination are unavailable.

PMID:40476643 | DOI:10.1111/vcp.70029

Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses

Latest publications - Fri, 06/06/2025 - 11:00

Emerg Microbes Infect. 2025 Jun 6:2511132. doi: 10.1080/22221751.2025.2511132. Online ahead of print.

ABSTRACT

The increasing spread of highly pathogenic avian influenza (HPAI) A/H5 viruses poses a pandemic threat. Circulating clade 2.3.4.4b viruses have demonstrated rapid transcontinental dissemination, extensive reassortment, epizootic spread and potential sustained mammal-to-mammal transmission, signifying a heightened risk of becoming a human pathogen of high consequence. A broadly protective, future-proof vaccine against multiple clades of H5 influenza is urgently needed for pandemic preparedness. Here, we combine two novel vaccine technologies to generate a Digitally Immune Optimised and Selected H5 antigen (DIOSvax-H5inter) displayed multivalently on the mi3 nanocage using the SpyTag003/SpyCatcher003 conjugation system. Mice immunised with DIOSvax-H5inter Homotypic Nanocages at low doses demonstrate potent, cross-clade neutralising antibody and T cell responses against diverse H5 strains. DIOSvax-H5inter Homotypic Nanocages provide a scalable vaccine candidate with the potential for pan-H5 protection against drifted or newly emergent H5 strains. This World Health Organization preferred characteristic is essential for prospective strategic stockpiling in the pre-pandemic phase.Trial registration: ClinicalTrials.gov identifier: NCT06145178..

PMID:40476519 | DOI:10.1080/22221751.2025.2511132

Comparative performance and age dependence of tuberculin and defined antigen bovine tuberculosis skin tests assessed with Bayesian latent class analysis

Latest publications - Thu, 05/06/2025 - 11:00

Sci Rep. 2025 Jun 5;15(1):19728. doi: 10.1038/s41598-025-05223-6.

ABSTRACT

Tuberculin skin tests (TST), the primary diagnostic tool for bovine tuberculosis (bTB), cross-react with BCG vaccine. Recently developed defined antigen skin tests (DSTs) aim to differentiate infected amongst vaccinated animals. We evaluated the field performance of different interpretations of the TST and DSTs relative to IGRA and IDEXX M. bovis antibody tests. This panel of tests was assessed in 446 unvaccinated cattle across 22 Ethiopian dairy herds using Bayesian latent class models. We extended the standard Walter-Hui model to include age-related effects to explore evidence of the presence of diagnostic anergy. The latent class models estimate sensitivity and specificity of the DSTs to be between 84-88% and 79-85% respectively. The DSTs perform intermediately between the comparative intradermal test (CIT, sensitivity 77%, specificity 100%) and single intradermal test (SIT, sensitivity 99%, specificity 76%). We observed significant age-related declines in test sensitivity, most notably for CIT (declining from 75 to 52% over 9 years) and DST10 (83% to 68%), while other tests showed more stable sensitivity across age groups. This variable pattern across tests suggests mechanisms beyond simple age-related anergy. Together, these findings demonstrate that DSTs' superior sensitivity to CIT and comparable or better specificity than SIT, combined with their ability to distinguish vaccinated animals, creates a viable pathway for implementing BCG vaccination programs. Given the absence of any gold standard definition of infection with bTB, latent class analyses are essential to assess the relative performance of different diagnostic tests. While our results provide encouraging news for the sensitivity of the new DST tests, the high prevalence of bTB within our study population makes our design underpowered to assess the specificity of the DSTs. Future research, including assessment of the specificity of DSTs in disease-free populations and optimization of test formulation and validation through large-scale field trials is essential to fully establish the case for use in vaccination and surveillance programs.

PMID:40473835 | DOI:10.1038/s41598-025-05223-6

Complication rate and outcomes of laryngeal cuneiformectomy in dogs with advanced laryngeal collapse

Latest publications - Tue, 03/06/2025 - 11:00

Vet Surg. 2025 Jun 2. doi: 10.1111/vsu.14270. Online ahead of print.

ABSTRACT

OBJECTIVE: To describe the complication rate and outcomes of dogs undergoing multilevel airway surgery for brachycephalic airway syndrome (BOAS) with and without the addition of uni- or bilateral cuneiformectomy.

STUDY DESIGN: Retrospective study.

ANIMALS: A total of 180 dogs undergoing BOAS surgery: 94 dogs undergoing modified multilevel surgery (non-PC); 86 additionally undergoing cuneiformectomy (PC).

METHODS: Case records from the University of Cambridge and Animal Health Trust databases between 2014 and 2021 were analyzed including data on laryngeal collapse grade, respiratory functional grading scores, BOAS index, hospitalization length and complications.

RESULTS: Neither the incidence risk of overall (non-PC = 19.4%, PC = 16.3%, p = .758), nor major (non-PC = 7.4%, PC = 11.6%, p = .482) complications differed between non-PC and PC dogs. Median hospitalization duration (non-PC = 1 day, PC = 1 day) did not differ between the two groups (p = .743). Both BOAS grade (median reduction = 1, p < .0001) and BOAS index (median reduction = 28.5%, p < .0001) reduced in dogs that underwent cuneiformectomy. Lower BCS was associated with increased postoperative complications (odds ratio = 0.452, p = .004) when preoperative BOAS grade and gender were controlled.

CONCLUSION: Cuneiformectomy was not associated with a higher incidence risk of complications than multilevel BOAS surgery alone. Significant improvements in respiratory parameters were observed following cuneiformectomy in addition to multilevel airway surgery.

CLINICAL SIGNIFICANCE: Cuneiformectomy represents a safe and effective adjunctive technique to manage higher grade laryngeal collapse in dogs with BOAS.

PMID:40457630 | DOI:10.1111/vsu.14270

Junior Clinical Training Scholar in Small Animal Studies X 6

Job opportunities - Sun, 01/06/2025 - 01:00

Six scholarships available to start on Monday 01 December 2025 for 12.5 months.

SCHOLARSHIP AWARD: £21,970.00 (TAX EXEMPT) per annum.

University accommodation package, see details below.

Applications are invited for this one-year post-graduate training programme based in the Queen's Veterinary School Small Animal Hospital. On site accommodation is available for £300 per month including bills.

Junior Clinical Training Scholars will receive training and tuition as they rotate through anaesthesia, cardiology, diagnostic imaging, orthopaedics, dermatology, internal medicine, neurology, oncology, clinical pathology and soft tissue surgery and be supervised by recognised specialists in each field. Scholars will also have responsibility for primary care cases, and be involved in supervision and guidance of final year veterinary students. Scholars will be an integral part of the out of hours care of animals within the hospital, especially within the intensive care unit.

Summary of benefits

  • High residency success rate - 74% of our interns have gone on to do a residency and 100% of interns who have been pursuing a residency have successfully achieved a residency or completed a specialist internship programme. We have 50 successful residency applications from intern cohorts 2015-2022 and 2217 diplomates, so far!
  • Competitive tax-free stipend including accommodation in Central Cambridge and bills included package
  • Truly rotating internship through all specialties including flexibility to pursue extra time in rotations of your choice!
  • Good work-life balance with manageable weekend and night work
  • University library and journal access
  • Monthly seminars with complimentary food and drink!
  • 4 weeks of elective/dedicated research time on top of holidays
  • Academic opportunities, e.g. teach Cambridge students during rotations and College supervision opportunities; weekly department research and clinical seminars; journal and book clubs
  • Proven track-record with publications and research projects with guidance on presentation and scientific writing skills.
  • Assigned intern supervisor: - regular progress meetings, interview practice, provision of professional references and CV/cover letter proof reading by experienced senior clinicians to aid residency applications
  • Generous CPD allowance and encouragement to present at scientific meetings
  • RECOVER CPR training
  • First opinion service including surgical cases
  • A number of service-specific internships and residency opportunities encourage career progression following internship

Candidates must be Members of the Royal College of Veterinary Surgeons (RCVS) and the following skills and experience are desirable: - Surgical experience in dogs and cats - Completion of 1 year in primary care veterinary practice in the UK - For applicants for whom English is not their first language, a score of 7.5 in IELTS (with no element under 7), or a score of 100 in TOEFL (with no element less than 24).

For further benefits and details on the Internship: https://www.vet.cam.ac.uk/study/cts/jcts1/smallanimal

Informal enquiries should be directed to the Internship Directors, by email: internship.enquiries@vet.cam.ac.uk.

Please note: The ability to take up this Scholarship is contingent upon you being able to evidence your right to work in the UK, or through gaining the right to work via the UK immigration system. Evidence will need to be provided before an offer can be made. Regrettably, this Scholarship is not suitable for sponsorship via the Skilled Worker or Temporary Worker visa routes as the minimum requirements cannot be met.

An application form (JCTS1) and information pack can be downloaded from the link below or via the following website: http://www.vet.cam.ac.uk/job

Applicants should supply a completed Junior Clinical Training Scholarship Application Form (JCTS 1), a CV and Covering Letter giving reasons for wishing to undertake the JCTS in the Department of Veterinary Medicine, University of Cambridge.

Applications should be submitted via e-mail to: vetmed@vet.cam.ac.uk with the above documents as one attachment, by the closing date stated. Please quote reference PP46094 on your application and in any correspondence about this vacancy.

The deadline for applications is midnight on Monday 30 June 2025.

Applications will be monitored regularly, and we may contact candidates prior to the closing date. We reserve the right to close this vacancy early if we receive sufficient applications or extend the closing date if necessary. Therefore, if you are interested, please submit your application as early as possible.

The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.

Junior Clinical Training Scholar in Diagnostic Imaging

Job opportunities - Fri, 30/05/2025 - 01:00

Scholarship award: £21,970.00 (Tax Exempt) per annum.

University accommodation package, see details below.

Start date: from 15 July 2025, or as soon as possible thereafter, for 12 months.

Applications are invited from recently qualified veterinarians for this twelve month post-graduate training programme offering high-quality, post-graduate training in Veterinary Diagnostic Imaging. The emphasis will be on gaining practical clinical experience in Veterinary Diagnostic Imaging under the supervision of board-certified diplomates. On site accommodation is available for £300 per month including bills.

Applicants must be a Member of the Royal College of Veterinary Surgeons or hold a veterinary degree qualifying them for membership.

Summary of benefits

  • Competitive tax-free stipend including accommodation in Central Cambridge and bills included package
  • Good work-life balance with manageable weekend and night work
  • University library and journal access
  • Academic opportunities, e.g. teach Cambridge students during rotations and College supervision opportunities; weekly department research and clinical seminars; journal and book clubs
  • Proven track-record with publications and research projects with guidance on presentation and scientific writing skills.
  • Assigned intern supervisor: - regular progress meetings, interview practice, provision of professional references and CV/cover letter proof reading by experienced senior clinicians to aid residency applications
  • Generous CPD allowance and encouragement to present at scientific meetings

We would welcome anyone wishing to apply for this scholarship to arrange a visit to the hospital to meet the team and find out more. To arrange a visit to the hospital and for informal enquiries about the scholarship programme, please contact Marie-Aude Genain on mag72@cam.ac.uk.

Please note: The ability to take up this Scholarship is contingent upon you being able to evidence your right to work in the UK, or through gaining the right to work via the UK immigration system. Evidence will need to be provided before an offer can be made. Regrettably, this Scholarship is not suitable for sponsorship via the Skilled Worker or Temporary Worker visa routes as the minimum requirements cannot be met.

An application form (JCTS1) and information pack can be downloaded from the link below or via the following website: http://www.vet.cam.ac.uk/job

Applicants should supply a completed Junior Clinical Training Scholarship Application Form (JCTS 1), a CV and Covering Letter giving reasons for wishing to undertake the JCTS in the Department of Veterinary Medicine, University of Cambridge.

Applications should be submitted via e-mail to: vetmed@vet.cam.ac.uk with the above documents as one attachment, by the closing date stated.

The deadline for applications is midnight on Sunday, 22 June 2025.

Please quote reference PP46093 on your application and in any correspondence about this vacancy.

The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.

Bacteriophage-Antibiotic Synergy Enhances Therapeutic Efficacy Against Multidrug-Resistant Klebsiella Pneumoniae Infections

Latest publications - Thu, 29/05/2025 - 11:00

J Appl Microbiol. 2025 May 29:lxaf131. doi: 10.1093/jambio/lxaf131. Online ahead of print.

ABSTRACT

AIMS: This study aims to evaluate the therapeutic efficacy of bacteriophage therapy alone or in combination with antibiotics in the treatment of acute infection caused by multidrug-resistant (MDR) Klebsiella pneumoniae.

METHODS AND RESULTS: In this study, we isolated and characterized a lytic bacteriophage vB_Kpn_FOPMU1, which exhibits potent antibacterial activity against K. pneumoniae. Whole-genome sequencing identified vB_Kpn_FOPMU1 as a member of the Przondovirus genus and revealed the presence of key lysis-associated genes, including those encoding endolysin, holin, and Rz-like spanin proteins. In vitro work demonstrated that incubation of bacteriophage and cefotaxime with K. pneumoniae significantly decreased the MIC of cefotaxime from 128µg mL-1 to 1 µg mL-1, indicating strong synergistic activity. Using a murine model of acute K. pneumoniae lung infection, we further demonstrated that the combination therapy significantly enhanced bacterial clearance compared to phage monotherapy. This synergistic approach restored sensitivity of K. pneumoniae to cefotaxime, prevented the emergence of phage-resistant bacterial mutants, and achieved superior bacterial eradication from both the lung and blood. Moreover, administration of the phage-antibiotic combination resulted in complete protection of infected mice, with a 100% survival rate, compared to a 60% survival rate observed in animals that received phage monotherapy. Therapeutic application of the bacteriophage-cefotaxime combination resulted in significantly improved lung pathology, characterized by reduced inflammatory cell infiltration and diminished tissue damage, compared to bacteriophage monotherapy.

CONCLUSION: Our findings underscore the potential of bacteriophage-antibiotic synergy as a promising therapeutic strategy to combat MDR K. pneumoniae infections and mitigate the risk of phage resistance development.

PMID:40440204 | DOI:10.1093/jambio/lxaf131

Single-cell transcriptomic analysis of canine insulinoma reveals distinct sub-populations of insulin-expressing cancer cells

Latest publications - Thu, 29/05/2025 - 11:00

Vet Oncol. 2025;2(1):13. doi: 10.1186/s44356-025-00026-3. Epub 2025 May 26.

ABSTRACT

Canine malignant insulinoma is a rare, highly metastatic and life-threatening neuroendocrine tumour of pancreatic beta cells. To map the single-cell transcriptomic landscape of canine insulinoma for the first time, transcriptomic profiles of 5,532 cells were captured from two spontaneous insulinomas (Patient 1 and 2) and one associated metastasis (Patient 2) in two Boxer dogs. Distinct cancer, endocrine, and immune cell populations were identified. Notably, all three tumour samples contained two transcriptionally distinct insulin-expressing tumour cell populations (INS+ and INS+FOS low ), characterised here for the first time. These two cancer cell populations significantly differed by ~ 8,000 differentially expressed genes (DEGs), particularly tumour suppressor genes (e.g. TP53, EGR1) and cancer-related pathways (e.g., MAPK, p53). In contrast, COX7A2L was one of a few genes ubiquitously expressed and significantly upregulated (> 20-fold) in both insulin-expressing tumour populations compared to other captured populations. Both populations were also characterised by expression of chromogranin/secretogranin neuroendocrine tumour marker genes (e.g. CHGA, SCGN). There were far fewer gene expression differences observed between insulin-expressing tumour cells from the two patients (~ 600 DEGs) than between the two cancer cell populations within each patient. These DEGs included CLTRN, TMSB4X, CSRP2, LGALS2, and C15orf48. Unexpectedly for a tumour of endocrine origin, the metastasis in Patient 2 exhibited > 20-70 fold upregulation of exocrine pancreatic genes including CLPS, PRSS2, PRSS and CTRC. Immune cell analyses identified distinct infiltrating immune populations, including memory T cells and macrophages and revealed likely tumour-immune interactions, including the CD40-CD40L interaction. This study provides the first single-cell RNA sequencing (scRNA-seq) analysis of naturally occurring insulinoma in any species, revealing tumour cell heterogeneity, novel immune microenvironment features, and potential therapeutic targets. Despite its small scale, the findings highlight the utility of scRNA-seq in veterinary oncology and its translational potential for pancreatic neuroendocrine tumours across species.

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s44356-025-00026-3.

PMID:40438247 | PMC:PMC12106163 | DOI:10.1186/s44356-025-00026-3

Breaking the cycle of parasitic diseases with edutainment: The intersection of entertainment and education

Latest publications - Wed, 28/05/2025 - 11:00

PLoS Negl Trop Dis. 2025 May 28;19(5):e0013072. doi: 10.1371/journal.pntd.0013072. eCollection 2025 May.

ABSTRACT

Parasitic diseases represent a substantial public health challenge worldwide. Traditional educational strategies have often fallen short in driving sustained behavioral shifts that are nonetheless essential for reducing the burden of these diseases. Edutainment, a blend of education and entertainment, is the synthesis of pedagogical content with recreational frameworks, leveraging narrative and visual appeal to elevate the learning experience through enriched experiences, aligning with the principles of "warm cognition". Human cognitive processes, including attention, learning and memory, are influenced by emotions. As a result, emotional experiences are remembered vividly and accurately, with great resilience over time. Several edutainment approaches have been successfully utilized to inspire positive behavioral changes against soil-transmitted helminths (STHs), schistosomiasis, echinococcosis, and other diseases. This scoping review delves into several documented approaches with sustainable positive post-intervention outcomes. Approaches such as animated cartoons, gamification, songs, videos, and music, mobile health applications, hands-on experience, posters, comics and educational booklets, puppet shows, toy animals, cardboard and plastic-coated drawings, drawing activities and competitions, group discussions, illustrated booklets and questionnaires have yielded statistically significant improvements in participant's knowledge related to parasitic diseases (up to 60% increase in knowledge scores), alongside notable reductions in risks of parasite transmission and infection prevalence. These improvements highlight the potential of edutainment to enhance community awareness, promote long-term behavioral changes, and ultimately contribute to reducing spread of disease. Moreover, artificial intelligence (AI) can be integrated into edutainment approaches to meet the growing demand for personalized and effective learning methods. We argue that such AI-driven edutainment can underpin sustainable progress in the control of parasitic diseases.

PMID:40435280 | DOI:10.1371/journal.pntd.0013072

Epithelial damage and ageing: the perfect storm

Latest publications - Tue, 27/05/2025 - 11:00

Thorax. 2025 May 27:thorax-2024-222060. doi: 10.1136/thorax-2024-222060. Online ahead of print.

ABSTRACT

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive disease of lung parenchymal scarring that is triggered by repeated microinjury to a vulnerable alveolar epithelium. It is increasingly recognised that cellular ageing, whether physiological or accelerated due to telomere dysfunction, renders the epithelium less able to cope with injury and triggers changes in epithelial behaviour that ultimately lead to the development of disease.

AIMS: This review aims to highlight how, with increasing age, the alveolar epithelium becomes vulnerable to exogenous insults. We discuss the downstream consequences of alveolar epithelial dysfunction on epithelial phenotype, alveolar repair and pro-pathogenic interactions with other alveolar niche-resident cell types which drive IPF pathogenesis.

NARRATIVE: We highlight how a wide array of cellular mechanisms that maintain cellular homeostasis become dysfunctional with ageing. Waning replicative capacity, genomic stability, mitochondrial function, proteostasis and metabolic function all contribute to a phenotype of vulnerability to 'second hits'. We discuss how in IPF the alveolar epithelium becomes dysfunctional, highlighting changes in repair capacity and fundamental cellular phenotype and how interactions between abnormal epithelium and other alveolar niche-resident cell types perpetuate disease.

CONCLUSIONS: The ageing epithelium is a vulnerable epithelium which, with the cumulative effects of environmental exposures, fundamentally changes its behaviour towards stalled differentiation, failed repair and profibrotic signalling. Further dissection of aberrant epithelial behaviour, and its impact on other alveolar cell types, will allow identification of novel therapeutic targets aimed at earlier pathogenic events.

PMID:40425299 | DOI:10.1136/thorax-2024-222060

Clinical Pathology Administrator

Job opportunities - Fri, 23/05/2025 - 01:00

Are you passionate about administration and supporting a Clinical Pathology team within a world-class research and education institution?

We have an exciting opportunity for a commercially minded Clinical Pathology Administrator to join our Clinical Pathology Laboratory at the Queen's Veterinary School Hospital. This is a full-time position working 36.5 hours a week, Monday to Friday.

The Queen's Veterinary School Hospital is a teaching and referral hospital with a reputation both nationally and internationally as a centre for excellence in many areas of veterinary medicine. The Clinical Pathology laboratory provides a range of services which are critical to the timely diagnosis of conditions of patients presenting in the clinics as well as being involved in a number of research projects. As a Clinical Pathology Administrator, you will manage the end-to-end process of sample handling and reporting, playing a key role in supporting the team and maintaining efficient workflows within the Clinical Pathology department. Your work ensures timely processing and accurate tracking, vital for delivering fast and reliable test results to clients.

This role is suitable for someone with qualifications comparable to an HND/HNC, Level 4/5 vocational qualifications, or equivalent practical experience. The ideal candidate will possess both factual and theoretical knowledge in administration and demonstrate a strong commercial mindset. Key responsibilities include evaluating processes, assessing pricing structures, and establishing efficient administrative methods. You would work with dedicated laboratory and practice management software, as well as routine word processing and spreadsheets.

Why Join us?

  • Be a part of a prestigious institution renowned for its research and academic excellence
  • Work in a collaborative and supportive environment
  • 36 days annual leave per year including bank holidays
  • A generous pension scheme
  • Travel benefits, retail discounts at over 2,000 stores and much more via our benefits platform (Cambens)
  • Contribute to the success of a department dedicated to delivering excellence in veterinary education and biomedical research

Informal enquiries can be made to Cassia Hare via email: chzh2@cam.ac.uk. If you have any queries regarding the application process, please contact Clinical HR via email: qvsh.hr@vet.cam.ac.uk.

Please quote reference PP46064 on your application and in any correspondence about this vacancy. Further particulars for the role and information about the Department can be found on www.vet.cam.ac.uk.

Click the 'Apply' button below to register an account with our recruitment system (if you have not already) and apply online.

Closing date: Sunday, 8 June 2025

We reserve the right to close this vacancy early if we receive sufficient applications or extend it if we do not receive a sufficient number of applications. Therefore, if you are interested, please submit your application as early as possible.

The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.

The University has a responsibility to ensure that all employees are eligible to live and work in the UK.

Opportunities and challenges for monitoring terrestrial biodiversity in the robotics age

Latest publications - Thu, 22/05/2025 - 11:00

Nat Ecol Evol. 2025 May 22. doi: 10.1038/s41559-025-02704-9. Online ahead of print.

ABSTRACT

With biodiversity loss escalating globally, a step change is needed in our capacity to accurately monitor species populations across ecosystems. Robotic and autonomous systems (RAS) offer technological solutions that may substantially advance terrestrial biodiversity monitoring, but this potential is yet to be considered systematically. We used a modified Delphi technique to synthesize knowledge from 98 biodiversity experts and 31 RAS experts, who identified the major methodological barriers that currently hinder monitoring, and explored the opportunities and challenges that RAS offer in overcoming these barriers. Biodiversity experts identified four barrier categories: site access, species and individual identification, data handling and storage, and power and network availability. Robotics experts highlighted technologies that could overcome these barriers and identified the developments needed to facilitate RAS-based autonomous biodiversity monitoring. Some existing RAS could be optimized relatively easily to survey species but would require development to be suitable for monitoring of more 'difficult' taxa and robust enough to work under uncontrolled conditions within ecosystems. Other nascent technologies (for instance, new sensors and biodegradable robots) need accelerated research. Overall, it was felt that RAS could lead to major progress in monitoring of terrestrial biodiversity by supplementing rather than supplanting existing methods. Transdisciplinarity needs to be fostered between biodiversity and RAS experts so that future ideas and technologies can be codeveloped effectively.

PMID:40404926 | DOI:10.1038/s41559-025-02704-9